Moderna, Inc.   (NASDAQ:MRNA)

127.17    $-10.45   -7.59%
Market open   Tuesday, May 24 2022 11:09 AM

Moderna, Inc. Chart

MRNA Stock Price Today

Moderna, Inc. (MRNA) stock plummeted over -7.59% intraday to trade at $127.17 a share on NASDAQ. The stock opened with a loss of -1.00% at $136.24 and touched an intraday high of $144.77, rising 5.20% against the last close of $137.62. The stock went to a low of $131.35 during the session.

Stock Snapshot

137.62
Prev. Close
136.24
Open
57.60B
Market Cap
402.00M
Number of Shares
131.35
day Low
144.77
Day High
127.17
3.75
P/E ratio
4.28%
Free Float in %
34.02
EPS (TTM)
42.48
Book Value per Share
24.17
Cash Flow per Share
1.94M
Volume

Moderna, Inc. Historical Data

DateOpenCloseDaily HighDaily LowVolume
2022-05-20$143.07$136.25$144.77$131.355,880,500
2022-05-19$140.87$143.38$148.50$140.467,708,100
2022-05-18$138.41$137.71$144.13$136.294,977,800
2022-05-17$137.52$142.28$143.89$136.095,960,700
2022-05-16$135.87$136.26$141.60$133.824,535,600
2022-05-13$132.31$137.91$141.65$132.316,491,100
2022-05-12$120.60$130.17$132.94$119.017,106,700
2022-05-11$130.74$123.43$134.91$122.727,409,300
2022-05-10$137.40$132.32$139.05$127.618,180,200
2022-05-09$132.79$135.80$141.65$131.789,625,800
2022-05-06$139.70$134.40$140.60$131.007,006,800

Contact Details

200 Technology Square
Cambridge, MA 02139
United States
https://www.modernatx.com
617 714 6500

Company Information

Employees1300
Beta1.64
Sales or Revenue22.60B
5Y Sales Change179.40%
Fiscal Year Ends2021-12-30
SectorHealthcare
IndustryBiotechnology

About Company

Moderna, Inc., a biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States and internationally. The company has 44 development programs, which includes 26 in clinical trials across seven modalities comprising prophylactic vaccines, systemic secreted and cell surface therapeutics, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic intracellular therapeutics, and inhaled pulmonary therapeutics. The company has strategic alliances with AstraZeneca PLC; Merck & Co., Inc.; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Carisma Therapeutics, Inc.; Metagenomi, Inc.; the Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation, as well as a collaboration and license agreement with Chiesi Farmaceutici S.P.A. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

Frequently Asked Questions

What is the current Moderna, Inc. (MRNA) stock price?

Moderna, Inc. (NASDAQ: MRNA) stock price is $127.17 as of the last check on Tuesday, May 24 2022. During the trading session, MRNA stock reached the peak price of $144.77 while $131.35 was the lowest point it dropped to.

MRNA's industry and sector of operation?

The NASDAQ listed MRNA is part of Biotechnology industry that operates in the broader Healthcare sector. Moderna, Inc., a biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States and internationally.

Who are the executives of MRNA?

Dr. Noubar B. Afeyan Ph.D.
Co-Founder, Independent Non Exec. Chairman & Member of Technology Advisory Board

Mr. Stephane Bancel
CEO & Director

Dr. Stephen Hoge M.D.
Pres

Dr. Tal Zaks
Chief Medical Officer


What is the MRNA stock price today?

MRNA stock is trading at $127.17 today, which is $-10.45 or -7.59% lower than its previous close of $137.62. MRNA's current trading price is -74.44% lower than its 52-week high of $497.49 where as its distance from 52-week low of $119.01 is 6.86%.

How many employees does MRNA have?

Number of MRNA employees currently stands at 1300. MRNA operates from 200 Technology Square
Cambridge, MA 02139
United States.

Link for MRNA official website?


How do I contact MRNA?

MRNA could be contacted at 200 Technology Square
Cambridge, MA 02139
United States, or at phone # 617 714 6500 and can also be accessed through its website: https://www.modernatx.com

How many shares of MRNA are traded daily?

MRNA stock volume so far today is 1.94M shares while in the previous session number of MRNA shares traded was 5.88M. The average number of MRNA shares traded daily for last 3 months was 7.11M.

How much did MRNA change today?

The percentage change in MRNA stock occurred in the recent session was -7.59% while the dollar amount for the price change in MRNA stock was $-10.45.

What price range MRNA stock been trading in?

In the recent session, the day high for MRNA stock was $144.77 while the low for MRNA stock touched on the day was $131.35.

What is the market cap of MRNA currently?

The market value of MRNA currently stands at $57.60B with its latest stock price at $127.17 and 402.00M of its shares outstanding.